Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1

BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh Li, Shu-Man, Liu, Shu-Ting, Chang, Yung-Lung, Ho, Ching-Liang, Huang, Shih-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238313/
https://www.ncbi.nlm.nih.gov/pubmed/30442142
http://dx.doi.org/10.1186/s12929-018-0478-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238313/
https://www.ncbi.nlm.nih.gov/pubmed/30442142
http://dx.doi.org/10.1186/s12929-018-0478-5

Ejemplares similares